Drug Free Solution, Inc. Proceeds from Contributed Capital
Drug Free Solution, Inc. reported Proceeds from Contributed Capital of $0 for the 9-month period ending 2014-02-28, per its 10-Q filed 2014-10-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2014-10-02
- Drug Free Solution, Inc. proceeds from contributed capital for the quarter ending 2014-02-28 was $0.00.
- Drug Free Solution, Inc. proceeds from contributed capital for the quarter ending 2013-11-30 was $0.00, a 100.00% decline year-over-year.
- Drug Free Solution, Inc. proceeds from contributed capital for the quarter ending 2013-08-31 was $0.00, a 100.00% decline year-over-year.
- Drug Free Solution, Inc. proceeds from contributed capital for the quarter ending 2013-05-31 was $376.58K.
- Drug Free Solution, Inc. proceeds from contributed capital for fiscal 2013 was $376.83K, a 41.63% decline from fiscal 2012.
- Drug Free Solution, Inc. proceeds from contributed capital for fiscal 2012 was $645.61K.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 6 month as first filed | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month | Proceeds from Contributed Capital 83 month | Proceeds from Contributed Capital 86 month | Proceeds from Contributed Capital 89 month | Proceeds from Contributed Capital 92 month | Proceeds from Contributed Capital 95 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-02 | $0.00 derived: sum of 2 quarters · filed 2014-10-02 | $0.00 10-Q · filed 2014-10-02 | $376.58K derived: sum of 4 quarters · filed 2014-10-02 | ||||||
| 2013-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-24 | $0.00 10-Q · filed 2014-01-24 | $376.58K derived: sum of 3 quarters · filed 2014-01-24 | $103.85K derived: sum of 4 quarters · filed 2014-10-02 | $1.02M 10-Q · filed 2014-01-24 | |||||
| 2013-08-31 | $0.00 10-Q · filed 2013-10-15 | $376.58K derived: sum of 2 quarters · filed 2013-10-15 | $103.85K derived: sum of 3 quarters · filed 2014-10-02 | $133.12K derived: sum of 4 quarters · filed 2014-10-02 | $1.02M 10-Q · filed 2013-10-15 | |||||
| 2013-05-31 | $376.58K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-10-02 | $103.85K derived: sum of 2 quarters · filed 2014-10-02 | $133.12K derived: sum of 3 quarters · filed 2014-10-02 | $376.83K 10-K/A · filed 2013-10-02 | $1.02M 10-K/A · filed 2013-10-02 | |||||
| 2013-02-28 | -$272.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-02 | -$243.47K derived: sum of 2 quarters · filed 2014-10-02 | $250.00 10-Q · filed 2014-10-02 | $250.00 10-Q · filed 2013-04-19 | ||||||
| 2012-11-30 | $29.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-24 | $272.98K 10-Q · filed 2014-01-24 | $42.25K 10-Q/A · filed 2013-10-02 | $2.18M 10-Q/A · filed 2013-10-02 | ||||||
| 2012-08-31 | $243.72K 10-Q · filed 2013-10-15 | |||||||||
| 2012-05-31 | $645.61K 10-K/A · filed 2013-10-02 | |||||||||
| 2012-02-29 | $0.00 10-Q · filed 2013-04-19 | |||||||||
| 2011-11-30 | $31.23K 10-Q/A · filed 2013-10-02 |